Avenue Therapeutics Inc. buy Maxim Group
Start price
11.12.23
/
50%
€0.13
Target price
11.12.24
€0.70
Performance (%)
-16.72%
End price
12.12.24
-
Summary
This prediction is currently being closed. The price of Avenue Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.72%. Maxim_Group has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avenue Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Maxim_Group for this prediction
In the thread Avenue Therapeutics Inc. diskutieren
Avenue Therapeutics, Inc. (NASDAQ: ATXI) is now covered by analysts at Maxim Group. They set a "buy" rating and a $0.75 price target on the stock.
Ratings data for ATXI provided by MarketBeat
In the thread Trading Avenue Therapeutics Inc.
Die von Maxim_Group gewählte maximale Laufzeit wurde überschritten